Author
Matteo Isolani
0 works0 citations
Recent research
- Health & Medicine
145 Implementing Vorasidenib in Clinical Practice: A Single-Centre Real-World Service Evaluation
Abstract Introduction The phase 3 INDIGO trial demonstrated significantly improved progression-free survival with Vorasidenib in patients with residual/recurrent IDH-mutant grade 2 oligodendroglioma and astrocytoma, supporting its integration into routine neuro-oncology practice....